Semin Respir Crit Care Med 2018; 39(04): 425-433
DOI: 10.1055/s-0038-1669412
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Diffuse Alveolar Hemorrhage and Pulmonary Vasculitides: Histopathologic Findings

Jason V. Scapa
1   Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
,
Gregory A. Fishbein
1   Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
,
W. Dean Wallace
1   Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
,
Michael C. Fishbein
1   Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
› Author Affiliations
Further Information

Publication History

Publication Date:
07 November 2018 (online)

Abstract

Vasculitides are a heterogeneous group of disorders in which inflammation of blood vessel walls is present at least some time during the course of the disease. Vasculitides can affect any caliber or type of vessel in many anatomic sites; however, the disease can alter more than just vasculature. Given the diversity of vasculitides, in 2012, a revised classification system was proposed to categorize vasculitides by the type of vessel involved including size, function, and structural attributes. In the lung, vasculitis impacts both the pulmonary vessels and parenchyma. Extrapulmonary involvement, particularly with concomitant kidney involvement, is a frequent occurrence. Pulmonary vasculitides often present with hemoptysis, pathologically manifested as diffuse alveolar hemorrhage (DAH) with or without capillaritis and can be life threatening when diffuse throughout the lungs. Etiologies for DAH include both primary and secondary vasculitides, along with collagen-vascular diseases, infection, and drug toxicity. Therefore, diagnosing the specific vasculitic etiology often relies on comprehensive assessment of all clinical, laboratory/serological, imaging, and histopathologic features that may be present. The most common primary pulmonary vasculitides often affect small vessels and are associated with circulating antineutrophilic cytoplasmic antibodies (ANCAs). In the 2012 classification, these include granulomatosis with polyangiitis (formerly Wegener granulomatosis), eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss' syndrome), and microscopic polyangiitis. Other less frequent vasculitides that are non-ANCA associated or affect medium- to large-sized vessels can have pulmonary involvement. These entities are usually associated with extrapulmonary disease and include polyarteritis nodosa, Takayasu's arteritis, Behçet's disease, and antibasement membrane antibody disease (formerly Goodpasture's syndrome). Although all vasculitides have vessel wall inflammation at some phase in the disease process, their histopathologic findings are as diverse as the group of diseases themselves. The characteristic histologic findings of the pulmonary vasculitides will be reviewed here.

 
  • References

  • 1 Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984; 63 (02) 65-81
  • 2 Mark EJ, Flieder DB, Matsubara O. Treated Wegener's granulomatosis: distinctive pathological findings in the lungs of 20 patients and what they tell us about the natural history of the disease. Hum Pathol 1997; 28 (04) 450-458
  • 3 Jennette JC, Falk RJ, Andrassy K. , et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37 (02) 187-192
  • 4 Jennette JC, Falk RJ, Bacon PA. , et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65 (01) 1-11
  • 5 Jennette JC, Thomas DB, Falk RJ. Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol 2001; 18 (01) 3-13
  • 6 Travis WD, Colby TV, Lombard C, Carpenter HA. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990; 14 (12) 1112-1125
  • 7 Colby TV, Fukuoka J, Ewaskow SP, Helmers R, Leslie KO. Pathologic approach to pulmonary hemorrhage. Ann Diagn Pathol 2001; 5 (05) 309-319
  • 8 Mark EJ, Ramirez JF. Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis. Arch Pathol Lab Med 1985; 109 (05) 413-418
  • 9 Green RJ, Ruoss SJ, Kraft SA, Duncan SR, Berry GJ, Raffin TA. Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 1996; 110 (05) 1305-1316
  • 10 Sherman JM, Winnie G, Thomassen MJ, Abdul-Karim FW, Boat TF. Time course of hemosiderin production and clearance by human pulmonary macrophages. Chest 1984; 86 (03) 409-411
  • 11 Kadokura M, Colby TV, Myers JL. , et al. Pathologic comparison of video-assisted thoracic surgical lung biopsy with traditional open lung biopsy. J Thorac Cardiovasc Surg 1995; 109 (03) 494-498
  • 12 Lendrum AC. Pulmonary haemosiderosis. Pathological aspects. Proc R Soc Med 1960; 53: 338-340
  • 13 Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest 2010; 137 (05) 1164-1171
  • 14 Milman N, Pedersen FM. Idiopathic pulmonary haemosiderosis. Epidemiology, pathogenic aspects and diagnosis. Respir Med 1998; 92 (07) 902-907
  • 15 Jennette JC. Overview of the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Clin Exp Nephrol 2013; 17 (05) 603-606
  • 16 Rao DA, Wei K, Merola JF. , et al. Myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and proteinase 3-ANCA without immunofluorescent ANCA found by routine clinical testing. J Rheumatol 2015; 42 (05) 847-852
  • 17 Kallenberg CG. Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitis. Curr Opin Rheumatol 2016; 28 (01) 8-14
  • 18 Savige J, Gillis D, Benson E. , et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999; 111 (04) 507-513
  • 19 McLaren JS, Stimson RH, McRorie ER, Coia JE, Luqmani RA. The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting. QJM 2001; 94 (11) 615-621
  • 20 Leavitt RY, Fauci AS, Bloch DA. , et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33 (08) 1101-1107
  • 21 Daum TE, Specks U, Colby TV. , et al. Tracheobronchial involvement in Wegener's granulomatosis. Am J Respir Crit Care Med 1995; 151 (2 Pt 1): 522-526
  • 22 Colby TV, Specks U. Wegener's granulomatosis in the 1990s--a pulmonary pathologist's perspective. Monogr Pathol 1993; (36) 195-218
  • 23 Yi ES, Colby TV. Wegener's granulomatosis. Semin Diagn Pathol 2001; 18 (01) 34-46
  • 24 Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997; 337 (21) 1512-1523
  • 25 Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest 1990; 97 (04) 906-912
  • 26 Kallenberg CG. Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol 2014; 10 (08) 484-493
  • 27 Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991; 15 (04) 315-333
  • 28 Lombard CM, Duncan SR, Rizk NW, Colby TV. The diagnosis of Wegener's granulomatosis from transbronchial biopsy specimens. Hum Pathol 1990; 21 (08) 838-842
  • 29 Uner AH, Rozum-Slota B, Katzenstein AL. Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener's granulomatosis. A clinicopathologic study of 16 cases. Am J Surg Pathol 1996; 20 (07) 794-801
  • 30 Travis WD. Common and uncommon manifestations of Wegener's granulomatosis. Cardiovasc Pathol 1994; 3 (03) 217-225
  • 31 Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004; 117 (01) 39-50
  • 32 Pelà G, Tirabassi G, Pattoneri P, Pavone L, Garini G, Bruschi G. Cardiac involvement in the Churg-Strauss syndrome. Am J Cardiol 2006; 97 (10) 1519-1524
  • 33 Hellemans S, Dens J, Knockaert D. Coronary involvement in the Churg-Strauss syndrome. Heart 1997; 77 (06) 576-578
  • 34 Niles JL, Böttinger EP, Saurina GR. , et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996; 156 (04) 440-445
  • 35 Matsumoto T, Homma S, Okada M. , et al. The lung in polyarteritis nodosa: a pathologic study of 10 cases. Hum Pathol 1993; 24 (07) 717-724
  • 36 Guillevin L, Lhote F, Amouroux J, Gherardi R, Callard P, Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol 1996; 35 (10) 958-964
  • 37 Kerr GS, Hallahan CW, Giordano J. , et al. Takayasu arteritis. Ann Intern Med 1994; 120 (11) 919-929
  • 38 Endo M, Tomizawa Y, Nishida H. , et al. Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis. J Thorac Cardiovasc Surg 2003; 125 (03) 570-577
  • 39 Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in Behcet disease: a cumulative analysis. Chest 2005; 127 (06) 2243-2253
  • 40 Uzun O, Erkan L, Akpolat I, Findik S, Atici AG, Akpolat T. Pulmonary involvement in Behçet's disease. Respiration 2008; 75 (03) 310-321
  • 41 Lombard CM, Colby TV, Elliott CG. Surgical pathology of the lung in anti-basement membrane antibody-associated Goodpasture's syndrome. Hum Pathol 1989; 20 (05) 445-451
  • 42 Tarzi RM, Cook HT, Pusey CD. Crescentic glomerulonephritis: new aspects of pathogenesis. Semin Nephrol 2011; 31 (04) 361-368
  • 43 Gmurczyk A, Ahya SN, Goldschmidt R, Kim G, Ho LT, Nash K. A case of simultaneous, biopsy-proven, classic, ANCA-positive Wegener's granulomatosis and anti-GBM disease, but without detectable circulating anti-GBM antibodies. Sci World J 2010; 10: 1078-1083
  • 44 Churg A, Carrington CB, Gupta R. Necrotizing sarcoid granulomatosis. Chest 1979; 76 (04) 406-413
  • 45 Lynch III JP, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med 1997; 18 (04) 755-785
  • 46 Isenberg JI, Goldstein H, Korn AR, Ozeran RS, Rosen V. Pulmonary vasculitis--an uncommon complication of ulcerative colitis. Report of a case. N Engl J Med 1968; 279 (25) 1376-1377
  • 47 Pagnoux C, Cohen P, Guillevin L. Vasculitides secondary to infections. Clin Exp Rheumatol 2006; 24 (2, Suppl 41): S71-S81
  • 48 Milburn DS, Myers CW. Tryptophan toxicity: a pharmacoepidemiologic review of eosinophilia-myalgia syndrome. DICP 1991; 25 (11) 1259-1262